The company has announced that the sole sponsor and overall coordinator, acting on behalf of the international underwriters, has fully exercised the over-allotment option as detailed in the prospectus on Tuesday, June 30, 2026.
This exercise involves a total of 2,128,950 H shares, representing approximately 15% of the total number of shares initially available under the global offering before any over-allotment option was exercised.
The H shares to be issued as a result of this exercise will be allotted and issued by the company at a price of HK$96.06 per H share.
The over-allotment shares will be used to facilitate the delivery of a portion of H shares to placees who have agreed to defer the delivery of their subscribed H shares under the global offering.
Comments